Status:
UNKNOWN
Mutation Analysis of 17α-Hydroxylase
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Pseudohermaphroditism
Congenital Adrenal Hyperplasia
Eligibility:
All Genders
Brief Summary
To elucidate the molecular pathology of the 4 families with 17α-hydroxylase/17,20-lyase deficiency.
Detailed Description
17α-hydroxylase is a rare form of congenital adrenal hyperplasia. Patients with complete 17α-hydroxylase deficiency may come to attention to the doctor at their early adulthood due to hypertension or ...
Eligibility Criteria
Inclusion
- Patients with 17α-hydroxylase deficiency and their family
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
End Date :
August 1 2005
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00172510
Start Date
August 1 2004
End Date
August 1 2005
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan